MAPRE3 and Ebola hemorrhagic fever: <h4>Introduction and methods</h4>While Ebola virus disease (EVD) remains a major threat, recent advances have led to the approval of several medical products, in particular the rVSVΔG-ZEBOV-GP vaccine (Ervebo) and two monoclonal antibody treatments, mAb114 (Ebanga) and REGN-EB3 (Inmazeb).